Evaluation of the ovarian reserve;L'évaluation de la réserve ovarienne

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 39, Issue 8 SUPPL. 2, 2010, Pages

  Ferte Delbende C ^a   Catteau Jonard, S ^a   Barrire, P ^b   Dewailly, D ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

AFC; AMH; Fertility; FSH; Inhibin B; IVF; Ovarian reserve; Ovarian volume

Indexed keywords

ESTRADIOL; FOLLITROPIN; INHIBIN B; MUELLERIAN INHIBITING FACTOR;

ARTICLE; CHEMOTHERAPY; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; FEMALE INFERTILITY; HUMAN; OVARIAN RESERVE; OVARY INSUFFICIENCY; PARTHENOGENESIS; PELVIC DISEASE; PREDICTION; STIMULATION;

EID: 78650828312     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0368-2315(10)70028-4     Document Type: Article

References (60)

1. H. Leridon Can assisted reproduction technology compensate for the natural decline in fertility with age? A model assessment Hum Reprod 19 2004 1548 1553
2. E.R. Te Velde, and P.L. Pearson The variability of female reproductive ageing Hum Reprod Update 8 2002 141 154
3. A.E. Treloar, R.E. Boynton, B.G. Behn, and B.W. Brown Variation of the human menstrual cycle through reproductive life Int J Fertil 12 1Pt2 1967 77 126
4. F.J. Broekmans, M.R. Soules, and B.C. Fauser Ovarian aging: mechanisms and clinical consequences Endocr Rev 30 2009 465 493
5. M. Voorhuis, N.C. Onland-Moret, Y.T. van der Schouw, B.C. Fauser, and F.J. Broekmans Human studies on genetics of the age at natural menopause: a systematic review Hum Reprod Update 16 2010 364 377
6. N.A. Lemos, E. Arbo, R. Scalco, E. Weiler, V. Rosa, and J.S. Cunha-Filho Decreased anti-Mullerian hormone and altered ovarian follicular cohort in infertile patients with mild/minimal endometriosis Fertil Steril 89 2008 1064 1068
7. H.J. Chang, S.H. Han, J.R. Lee, B.C. Jee, B.I. Lee, and C.S. Suh Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti-Mullerian hormone levels Fertil Steril 94 2010 343 349 Epub 2009 Apr 5
8. J. Donnez, B. Martinez-Madrid, P. Jadoul, A. Van Langendonckt, D. Demylle, and M.M. Dolmans Ovarian tissue cryopreservation and transplantation: a review Hum Reprod Update 12 2006 519 535
9. T. Brodin, T. Bergh, L. Berglund, N. Hadziosmanovic, and J. Holte Menstrual cycle length is an age-independent marker of female fertility: results from 6271 treatment cycles of in vitro fertilization Fertil Steril 90 2008 1656 1661
10. F.J. Broekmans, J. Kwee, D.J. Hendriks, B.W. Mol, and C.B. Lambalk A systematic review of tests predicting ovarian reserve and IVF outcome Hum Reprod Update 12 2006 685 718
11. M.R. Sowers, H. Zheng, D. Mc Connell, B. Nan, S. Harlow, and J.F. Randolph Jr. Follicle stimulating hormone and its rate of change in defining menopause transition stages J Clin Endocrinol Metab 93 2008 3958 3964
12. M.R. Sowers, H. Zheng, D. Mc Connell, B. Nan, S.D. Harlow, and J.F. Randolph Jr. Estradiol rates of change in relation to the final menstrual period in a population-based cohort of women J Clin Endocrinol Metab 93 2008 3847 3852
13. M. Grynberg, V. Genro, V. Gallot, A. El-Ali, R. Frydman, and R. Fanchin Early follicle development during the luteal-follicular transition affects the predictability of serum follicle-stimulating hormone but not antimullerian hormone levels on cycle day 3 Fertil Steril 94 2010 1827 1831
14. C.B. Lambalk, and C.H. de Koning Interpretation of elevated FSH in the regular menstrual cycle Maturitas 30 1998 215 220
15. J.W. Van der Steeg, P. Steures, M.J. Eijkemans, J.D. Habbema, P.G. Hompes, and F.J. Broekmans Predictive value and clinical impact of basal follicle-stimulating hormone in subfertile, ovulatory women J Clin Endocrinol Metab 92 2007 2163 2168
16. M.L. Haadsma, H. Groen, V. Fidler, A. Bukman, E.M. Roeloffzen, and E.R. Groenewoud The predictive value of ovarian reserve tests for spontaneous pregnancy in subfertile ovulatory women Hum Reprod 23 2008 1800 1807
17. J.P. Toner, C.B. Philput, G.S. Jones, and S.J. Muasher Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age Fertil Steril 55 1991 784 791
18. L.F. Bancsi, F.J. Broekmans, B.W. Mol, J.D. Habbema, and E.R. te Velde Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis Fertil Steril 79 2003 1091 1100
19. M.R. Sowers, A.D. Eyvazzadeh, D. Mc Connell, M. Yosef, M.L. Jannausch, and D. Zhang Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition J Clin Endocrinol Metab 93 2008 3478 3483
20. N.P. Groome, P.J. Illingworth, M. O'Brien, R. Pai, F.E. Rodger, and J.P. Mather Measurement of dimeric inhibin B throughout the human menstrual cycle J Clin Endocrinol Metab 81 1996 1401 1405
21. A. La Marca, G. Sighinolfi, D. Radi, C. Argento, E. Baraldi, and A.C. Artenisio Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART) Hum Reprod Update 16 2010 113 130
22. A. La Marca, G. Stabile, A.C. Artenisio, and A. Volpe Serum anti-Mullerian hormone throughout the human menstrual cycle Hum Reprod 21 2006 3103 3107
23. J. Van Disseldorp, M.J. Faddy, A.P. Themmen, F.H. de Jong, P.H. Peeters, and Y.T. van der Schouw Relationship of serum antimullerian hormone concentration to age at menopause J Clin Endocrinol Metab 93 2008 2129 2134
24. F.R. Tehrani, M. Solaymani-Dodaran, and F. Azizi A single test of antimullerian hormone in late reproductive-aged women is a good predictor of menopause Menopause 16 2009 797 802
25. A. De Vet, J.S. Laven, F.H. de Jong, A.P. Themmen, and B.C. Fauser Antimullerian hormone serum levels: a putative marker for ovarian aging Fertil Steril 77 2002 357 362
26. E. Arbo, D.V. Vetori, M.F. Jimenez, F.M. Freitas, N. Lemos, and J.S. Cunha-Filho Serum anti-mullerian hormone levels and follicular cohort characteristics after pituitary suppression in the late luteal phase with oral contraceptive pills Hum Reprod 22 2007 3192 3196
27. I. Streuli, T. Fraisse, C. Pillet, V. Ibecheole, P. Bischof, and D. de Ziegler Serum antimullerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids Fertil Steril 90 2008 395 400
28. A. Somunkiran, T. Yavuz, O. Yucel, and I. Ozdemir Anti-Mullerian hormone levels during hormonal contraception in women with polycystic ovary syndrome Eur J Obstet Gynecol Reprod Biol 134 2007 196 201
29. K.A. Mohamed, W.A. Davies, and H. Lashen Antimullerian hormone and pituitary gland activity after prolonged down-regulation with goserelin acetate Fertil Steril 86 2006 1515 1517
30. J. Van Disseldorp, C.B. Lambalk, J. Kwee, C.W. Looman, M.J. Eijkemans, and B.C. Fauser Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts Hum Reprod 25 2010 221 227
31. S.M. Nelson, R.W. Yates, H. Lyall, M. Jamieson, I. Traynor, and M. Gaudoin Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception Hum Reprod 24 2009 867 875
32. A. La Marca, F.J. Broekmans, A. Volpe, B.C. Fauser, and N.S. Macklon Anti-Mullerian hormone (AMH): what do we still need to know? Hum Reprod 24 2009 2264 2275
33. S.L. Broer, B.W. Mol, D. Hendriks, and F.J. Broekmans The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count Fertil Steril 91 2009 705 714
34. D.B. Seifer, D.T. MacLaughlin, B.P. Christian, B. Feng, and R.M. Shelden Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles Fertil Steril 77 2002 468 471
35. A. Hazout, P. Bouchard, D.B. Seifer, P. Aussage, A.M. Junca, and P. Cohen-Bacrie Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol Fertil Steril 82 2004 1323 1329
36. T. Ebner, M. Sommergruber, M. Moser, O. Shebl, E. Schreier-Lechner, and G. Tews Basal level of anti-Mullerian hormone is associated with oocyte quality in stimulated cycles Hum Reprod 21 2006 2022 2026
37. T. Silberstein, D.T. MacLaughlin, I. Shai, J.R. Trimarchi, G. Lambert-Messerlian, and D.B. Seifer Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology Hum Reprod 21 2006 159 163
38. S. Cupisti, R. Dittrich, A. Mueller, R. Strick, E. Stiegler, and H. Binder Correlations between anti-mullerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes Eur J Med Res 12 2007 604 608
39. J.M. Smeenk, F.C. Sweep, G.A. Zielhuis, J.A. Kremer, C.M. Thomas, and D.D. Braat Antimullerian hormone predicts ovarian responsiveness, but not embryo quality or pregnancy, after in vitro fertilization or intracyoplasmic sperm injection Fertil Steril 87 2007 223 226
40. S. Lie Fong, E.B. Baart, E. Martini, I. Schipper, J.A. Visser, and A.P. Themmen Anti-Mullerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality? Reprod Biomed Online 16 2008 664 670
41. F. Guerif, M. Lemseffer, M.L. Couet, O. Gervereau, V. Ract, and D. Royere Serum antimullerian hormone is not predictive of oocyte quality in vitro fertilization Ann Endocrinol (Paris) 70 2009 230 234
42. G.J. Scheffer, F.J. Broekmans, M. Dorland, J.D. Habbema, C.W. Looman, and E.R. te Velde Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility Fertil Steril 72 1999 845 851
43. M.L. Haadsma, A. Bukman, H. Groen, E.M. Roeloffzen, E.R. Groenewoud, and M.J. Heineman The number of small antral follicles (2-6 mm) determines the outcome of endocrine ovarian reserve tests in a subfertile population Hum Reprod 22 2007 1925 1931
44. K. Jayaprakasan, S. Deb, M. Batcha, J. Hopkisson, I. Johnson, and B. Campbell The cohort of antral follicles measuring 2-6 mm reflects the quantitative status of ovarian reserve as assessed by serum levels of anti-Mullerian hormone and response to controlled ovarian stimulation Fertil Steril 94 2010 1775 1781
45. W.J. Hehenkamp, C.W. Looman, A.P. Themmen, F.H. de Jong, E.R. te Velde, and F.J. Broekmans Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation J Clin Endocrinol Metab 91 2006 4057 4063
46. K. Elter, A. Sismanoglu, and F. Durmusoglu Intercycle variabilities of basal antral follicle count and ovarian volume in subfertile women and their relationship to reproductive aging: a prospective study Gynecol Endocrinol 20 2005 137 143
47. K. Jayaprakasan, K.F. Walker, J.S. Clewes, I.R. Johnson, and N.J. Raine-Fenning The interobserver reliability of off-line antral follicle counts made from stored three-dimensional ultrasound data: a comparative study of different measurement techniques Ultrasound Obstet Gynecol 29 2007 335 341
48. K. Jayaprakasan, B.K. Campbell, J.S. Clewes, I.R. Johnson, and N.J. Raine-Fenning Three-dimensional ultrasound improves the interobserver reliability of antral follicle counts and facilitates increased clinical work flow Ultrasound Obstet Gynecol 31 2008 439 444
49. S. Deb, K. Jayaprakasan, B.K. Campbell, J.S. Clewes, I.R. Johnson, and N.J. Raine-Fenning Intraobserver and interobserver reliability of automated antral follicle counts made using three-dimensional ultrasound and Sono AVC Ultrasound Obstet Gynecol 33 2009 477 483
50. S. Deb, M. Batcha, B.K. Campbell, K. Jayaprakasan, J.S. Clewes, and J.F. Hopkisson The predictive value of the automated quantification of the number and size of small antral follicles in women undergoing ART Hum Reprod 24 2009 2124 2132
51. D.J. Hendriks, J. Kwee, B.W. Mol, E.R. te Velde, and F.J. Broekmans Ultrasonography as a tool for the prediction of outcome in IVF patients: a comparative meta-analysis of ovarian volume and antral follicle count Fertil Steril 87 2007 764 775
52. D.J. Hendriks, B.W. Mol, L.F. Bancsi, E.R. te Velde, and F.J. Broekmans Antral follicle count in the prediction of poor ovarian response and pregnancy after in vitro fertilization: a meta-analysis and comparison with basal follicle-stimulating hormone level Fertil Steril 83 2005 291 301
53. D.H. Barad, A. Weghofer, and N. Gleicher Comparing anti-Mullerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function Fertil Steril 91 4 Suppl 2009 1553 1555
54. D.J. Hendriks, B.W. Mol, L.F. Bancsi, E.R. te Velde, and F.J. Broekmans The clomiphene citrate challenge test for the prediction of poor ovarian response and nonpregnancy in patients undergoing in vitro fertilization: a systematic review Fertil Steril 86 2006 807 818
55. A. Maheshwari, A. Gibreel, S. Bhattacharya, and N.P. Johnson Dynamic tests of ovarian reserve: a systematic review of diagnostic accuracy Reprod Biomed Online 18 2009 717 734
56. M. McIlveen, J.D. Skull, and W.L. Ledger Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population Hum Reprod 22 2007 778 785
57. T.E. Verhagen, D.J. Hendriks, L.F. Bancsi, B.W. Mol, and F.J. Broekmans The accuracy of multivariate models predicting ovarian reserve and pregnancy after in vitro fertilization: a meta-analysis Hum Reprod Update 14 2008 95 100
58. Jayaprakasan K, Campbell B, Hopkisson J, Johnson I, Raine-Fenning N. A prospective, comparative analysis of anti-Mullerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation. Fertil Steril;93:855-64.
59. W.G. Wood Has the introduction of the European Parliament Directive 98/79/EC from 1998-10-27 - concerning in-vitro diagnostic devices (IVD-directive) - influenced performance of hormone immunoassay kits in terms of precision and accuracy? Results from selected external quality assessment (EQA) schemes between 1993 and 2008 Clin Lab 55 2009 86 105
60. S.A. Amer, T.C. Li, C. Bygrave, A. Sprigg, H. Saravelos, and I.D. Cooke An evaluation of the inter-observer and intra-observer variability of the ultrasound diagnosis of polycystic ovaries Hum Reprod 17 2002 1616 1622